These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 19469257)

  • 21. Prokinetics in the Management of Functional Gastrointestinal Disorders.
    Quigley EMM
    Curr Gastroenterol Rep; 2017 Sep; 19(10):53. PubMed ID: 28887755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prokinetics of gastrointestinal system; its newer aspects with regard to motillity stimulants].
    Hongo M; Satake M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():382-8. PubMed ID: 11979811
    [No Abstract]   [Full Text] [Related]  

  • 23. The substituted benzamides in gastroenterology.
    Nowak TV; Schulze-Delrieu K
    Adv Biochem Psychopharmacol; 1982; 35():195-203. PubMed ID: 6756061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders.
    Peeters TL
    Curr Opin Pharmacol; 2006 Dec; 6(6):553-8. PubMed ID: 17011824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy of gastrointestinal motility disorders: moving in the right direction.
    Kuemmerle JF
    Gastroenterologist; 1994 Jun; 2(2):166-73. PubMed ID: 8055241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nervous and digestive manifestations in chronic alcoholism. Their treatment by tiapride].
    Naudy B
    Sem Hop; 1978 Apr; 54(9-12):466-8. PubMed ID: 210520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of a new preparation in upper digestive processes].
    Maldonado Eloy-García J; Escalante Llamas A; Ariza Moscoso A; Moreno López JM; Pérez Olivares J
    Rev Esp Enferm Apar Dig; 1974 Apr; 43(1):89-108. PubMed ID: 4840627
    [No Abstract]   [Full Text] [Related]  

  • 29. Access options for withdrawn motility-modifying agents.
    Jones MP
    Am J Gastroenterol; 2002 Sep; 97(9):2184-8. PubMed ID: 12358230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the pharmacology of gastrointestinal prokinetics.
    Tonini M
    Pharmacol Res; 1996; 33(4-5):217-26. PubMed ID: 8938012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of new gastro-intestinal prokinetic (ENGIP-I) study.
    Walwaikar PP; Kulkarni SS; Bargaje RS
    J Indian Med Assoc; 2005 Oct; 103(10):559-60. PubMed ID: 16498771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathogenetic therapy of motor disorders of the gastrointestinal tract in the postoperative period and in peritonitis].
    Shal'kov IuL; Artmov VI; Lazarev AV
    Vestn Khir Im I I Grek; 1980 Aug; 125(8):37-42. PubMed ID: 7423786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Itopride for functional dyspepsia.
    Taylor KM; Harris AW
    N Engl J Med; 2006 Jun; 354(22):2392; author reply 2392. PubMed ID: 16738281
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
    Dobrek Ł; Thor PJ
    Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo.
    Tsubouchi T; Saito T; Mizutani F; Yamauchi T; Iwanaga Y
    J Pharmacol Exp Ther; 2003 Aug; 306(2):787-93. PubMed ID: 12724347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mosapride in gastrointestinal disorders.
    Curran MP; Robinson DM
    Drugs; 2008; 68(7):981-91. PubMed ID: 18457463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of the functional disorders and motor disorders of the upper digestive tract with a new pharmacological preparation acting on the brain stem centers].
    Almeida Júnior N
    Hospital (Rio J); 1966 Oct; 70(4):863-82. PubMed ID: 5301842
    [No Abstract]   [Full Text] [Related]  

  • 38. [MODERN PROKINETICS AND THEIR ROLE IN THE TREATMENT OF GASTROENTEROLOGICAL PATHOLOGY].
    Sheptulin AA; Belousova IB
    Klin Med (Mosk); 2016; 94(3):178-82. PubMed ID: 27522721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The onset of physiological activity in the stomach in the postoperative period. A comparative study with a prokinetic preparation, Ganaton].
    Frasko R; Maruna P; Gürlich R
    Rozhl Chir; 2004 Oct; 83(10):527-30. PubMed ID: 15663103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prokinetic drugs in gastroenterology].
    Galmiche JP; Bruley des Varannes S; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.